Psoriasis cells and tissue products are obtained from volunteers participating in an Institutional Review Board (IRB) or Human Subject Committee approved donor program. All donors sign an informed consent form and are aware that these cells are used for research purposes. Donors must be over the age of 18.
See our entire Psoriasis cells product listing below.
Psoriasis is an autoimmune disease that appears on the skin and occurs when epidermal cells cause an immune response that in turn speeds up the growth cycle of skin cells. Psoriasis has been linked to an increase risk of stroke.
The disorder is a chronic recurring condition that varies in severity from minor localized patches to complete body coverage. Psoriasis can also cause inflammation of the joints which is known as psoriatic arthritis. Between 10-30% of all people with psoriasis experience psoriatic arthritis.
The cause of psoriasis is not fully understood but it is believed to have a genetic component. Various environmental factors have been suggested as aggravating to psoriasis including stress and withdrawal of systemic corticosteroids.
Psoriasis has a large hereditary component involving many genes however it is unclear how these genes work together. Many involve the immune system, particularly the major histocompatibility complex (MHC) and T cells.
Psoriasis specimens can be used in preclinical research, drug discovery, drug toxicity, biomarker development, and pre-selection of indication for clinical trials.